A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: • Primary objective: to evaluate the effect of intravenous melatonin (IVM) on mortality in adult patients admitted to the intensive care unit (ICU) with COVID-19. • Secondary objectives: ◦ To evaluate the effect of IVM on ICU length of stay. ◦ To evaluate the effect of IVM on the length...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Rubio, Miguel, Figueira, Juan Carlos, Acuña-Castroviejo, Darío, Borobia, Alberto M., Escames, Germaine, de la Oliva, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403786/
https://www.ncbi.nlm.nih.gov/pubmed/32758298
http://dx.doi.org/10.1186/s13063-020-04632-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403786/
https://www.ncbi.nlm.nih.gov/pubmed/32758298
http://dx.doi.org/10.1186/s13063-020-04632-4

Ejemplares similares